Related Experiment Video
Updated: Jul 13, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
A Review of Antibiotic Efficacy in COVID-19 Control
Hamidreza Hekmat1, Aziz Rasooli2, Zeinab Siami3
1Cardiology Department, Ziaeian Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:
Severe acute respiratory disease is associated with chronic secondary infections that exacerbate symptoms and mortality. So far, many drugs have been introduced to treat this disease, none of which effectively control the coronavirus. Numerous studies have shown that mitochondria, as the center of cell biogenesis, are vulnerable to drugs, especially antibiotics. Antibiotics were widely prescribed during the early phase of the pandemic. We performed a literature review to assess the reasons, evidence, and practices on the use of antibiotics in coronavirus disease 2019 (COVID-19) in- and outpatients. The current research found widespread usage of antibiotics, mostly in an empirical context, among COVID-19 hospitalized patients. The effectiveness of this approach has not been established. Given the high death rate linked with secondary infections in COVID-19 patients and the developing antimicrobial resistance, further study is urgently needed to identify the most appropriate rationale for antibiotic therapy in these patients.
Insights
Antibiotics were frequently used for hospitalized coronavirus disease (COVID-19) patients, often without clear evidence of effectiveness. Further research is crucial to establish appropriate antibiotic use and combat antimicrobial resistance in COVID-19 care.
Area of Science:
- Infectious Diseases
- Pharmacology
- Critical Care Medicine
Background:
- Severe acute respiratory disease, including coronavirus disease (COVID-19), is often complicated by secondary infections, increasing mortality.
- Mitochondria, crucial for cellular processes, are susceptible to various drugs, including antibiotics, which were widely used during the COVID-19 pandemic.
- The emergence of antimicrobial resistance poses a significant threat, particularly in the context of widespread antibiotic use for viral infections.
Purpose of the Study:
- To review the literature on the reasons, evidence, and practices surrounding antibiotic use in coronavirus disease 2019 (COVID-19) patients.
- To assess the empirical use of antibiotics in hospitalized COVID-19 patients and its established effectiveness.
- To highlight the urgent need for further research into appropriate antibiotic therapy for COVID-19, considering secondary infections and antimicrobial resistance.
Main Methods:
- A comprehensive literature review was conducted.
- The review focused on studies examining antibiotic prescription patterns, indications, and outcomes in both inpatient and outpatient COVID-19 settings.
- Evidence regarding the efficacy of antibiotic treatment in COVID-19 patients was critically evaluated.
Main Results:
- Antibiotic use was found to be widespread among hospitalized COVID-19 patients, frequently administered empirically.
- The effectiveness of this empirical antibiotic approach in managing COVID-19 has not been clearly established.
- Secondary infections contribute significantly to the high mortality rates observed in COVID-19 patients.
Conclusions:
- The empirical use of antibiotics in COVID-19 patients requires further investigation to determine its true benefit.
- Developing clear guidelines for antibiotic therapy is essential to address secondary infections and mitigate the growing problem of antimicrobial resistance.
- Future research should focus on identifying the most appropriate rationale for antibiotic administration in COVID-19 management.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Biological Methods for Microbial Control
Gene Regulation in Microbial Communities: Quorum Sensing